A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.

NCT00389298 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: VCH-759 (BCH-27759)

Sponsor

Vertex Pharmaceuticals Incorporated

Collaborators

[object Object]